It is undoubtable that virtual reality and augmented reality will soon be an integral part of our daily lives at home, in education, and at work. Here, we look at some of the exciting projects that Dr William Hurst of the Department of Computer Science at Liverpool John Moores University is driving forward and read how he is embracing virtual reality and augmented reality to enhance teaching and education, providing insight into how such technology may be utilised in the not too distant future.

Virtual Reality and Augmented Reality

Virtual reality (VR) and augmented reality (AR) have increased in prominence and public interest in recent years, leaping from the pages of science fiction into our homes and workplaces. Although still perhaps seen more as a novelty or a ‘must-have gadget’ at present, with ever-faster computing speeds and capacity, the future of VR and AR has the potential to become routinely embedded as an enhancement to all aspects of our domestic, educational, and working lives.

VR and AR differ in several ways. VR is a computer-simulated 3D-environment in which the user wears a bulky headset over their eyes, to become fully immersed (at least visually) in a different virtual environment. The user can interact with and navigate through the often stunningly realistic virtual world, but as a downside, they are effectively cut-off from the real world until they remove their headset or switch off their VR app again.

In comparison to VR, augmented reality allows the user to remain in the real world, aware of their surroundings and those around them but superimposes 2D or 3D computer simulations in real-time onto their field of vision, perhaps through transparent visors or spectacles, to add animations or layers of useful or contextual information.

The VR panda teddy bear avatar used during proton therapy

Preparing for Industry 4.0

Dr William Hurst is dedicated to the development of new technologies to support the transition of the UK’s industry into the new manufacturing paradigm – industry 4.0. The fourth industrial revolution is the next stage of manufacturing; taking us into a new phase of autonomous systems driven by access to vast quantities of data and machine learning. The UK has a lower productivity record in comparison with its worldwide competitors, and so productivity-enhancing systems are critical to the nation’s future success.

In light of this, InnovateUK funded a project in this area, called Productivity Accelerator (ProAccel). The £102,000 ProAccel project, led by Dr Hurst, was a business and community-centric modular cloud-based multimedia platform. It utilised advanced data analytics and gamification techniques, like AR and VR, to dramatically improve the way productivity information is utilised so that it can support businesses in the new digitally oriented world.

Amongst the prototype’s early test applications, the team tested a prototype tower crane cockpit simulator to improve the productivity of training of crane operators, enabling them to learn in a safe but highly realistic 3D virtual environment.

AR Molecular Interaction.

The VR Proton Beam Therapy Unit

Dr Hurst’s current research includes several collaborative projects exploring the use of creative VR and AR technologies to augment or revamp current ways of working, with a particular focus on medical and educational settings. An exciting example of this creative approach is Dr Hurst’s joint work with Kieran Latham, and Imagin3D of Daresbury Laboratories in Warrington, to create a virtual reality proton beam hospital therapy unit. This work originated through an innovation award to explore the use of AR and VR to increase the productivity of UK businesses. The technology the team has produced has both productivity-enhancing and humanitarian benefits.

Two new hospital-based proton therapy centres have been built in the UK to aid the treatment of different types of cancers and are particularly useful for childhood cancers. The proton beam treatment process, however, can be an intimidating and frightening experience for children as it involves lying inside a large spherical machine for a prolonged period while radiation is directed towards their tumour cells to destroy them.

Children are typically allocated a two-hour time slot to receive their proton therapy treatment; but often this may be insufficient, as significant time may be required to reassure the understandably apprehensive child to enter the machine for treatment, and to remain still throughout the process. Clinical schedules may overrun, or treatment may not be completed if the child is uncooperative. The team have addressed this challenge by developing a VR application that allows children between the age of 3 to 11 to experience the proton beam unit’s processes and preparation for treatment, initially through a VR experience. A VR panda teddy bear avatar is used to engage with the child and reassures their anxieties as they are guided through the proton beam therapy process.

While the idea is simple, the VR development process, working with a building information model (BIM), is highly complex. In brief, BIM is the process to recreate a detailed 3D model of a real-world object or environment, using 3D scanners to create point cloud data. In fact, such scans are often too detailed for VR use, comprising close to a five million polygon resolution, and so much of the app’s development is to manually simplify the scanned models, removing superfluous details by hand. The optimisation process results in a much lower polygon count model that is suitable for deployment into a VR game engine. The proton beam therapy unit VR application is being developed with Unreal Engine software that places the digitised model into a physically dynamic and realistically textured environment. It allows the application of industry-standard gaming models to achieve game-play levels of responsiveness for users.

Dr John Barrow, Aberdeen University, UK

Augmented Reality for Undergraduate Teaching

Dr Hurst has also recently worked on the development of an award-winning idea (awarded best paper at VISUAL2019), to use augmented reality to enhance life-science education. Led by Dr John Barrow at Aberdeen University, the project aims to develop experiential learning methods using AR cutting edge gaming technology to improve undergraduate teaching.

Dr Barrow’s interest is directed towards modernising the way life-sciences are taught at university. Dr Barrow’s experience of teaching bioscience and medical students over many years has led him to the conclusion that students often struggle to grasp the complex and abstract nature of molecular interactions and structures within biochemistry and cellular biology. Traditional teaching methods and textbooks have relied on rote learning and static two-dimensional cartoons or symbolic line representations of what are in reality, highly dynamic processes that are hard to then visualise in three dimensions.

Working with Dr Hurst and Imagin3D, Dr Barrow was keen to apply gamification techniques to create more suitable teaching material for the digitally literate generation of students. Gamification is where aspects of gaming technology and approaches are used in a non-game context. In addition, AR could be used to visually bring to life molecules and cellular activities as part of the classroom experience, and to offer new and engaging learning experiences that move away from purely didactic teaching.

Dr Barrow initially developed his software with Imagin3D and Dr Hurst to explain the complex metabolic processes in insulin signalling and will follow this up with a programme to visualise the glycolytic pathway, the biochemical process in the body to breakdown glucose for the production of energy. Both are fundamental to the teaching of cellular metabolism but are often taught in a linear fashion following the breakdown of one molecule to another in the pathways, a slightly dry and didactic process ripe for a modern make-over.

Student interns were involved to develop gaming aspects of the software with built-in challenges and problems to solve. For example, the students used game animations to build proteins through multiple pathways. The software development was focussed on utilising existing 3D molecular visualisations that are freely available online. These can be integrated into virtual environments, where the user can then interact and ‘play’ with them in a live situation to help them more intuitively understand their functions.

While this technology is still in its infancy, the potential for its wider use is enormous. The developed learning apps can be deployed digitally through VR, AR, platform-free videos and apps, as well as online. Medical applications could be used, for example, for health professional and patient education, to convey complex ideas or explain treatment procedures.

The team at Imagin3D

The Future of VR and AR

The integration of VR and AR integration into our daily lives will ultimately become a seamless part of our perception of the world around us within just a few decades. Dr Hurst’s work demonstrating the wider uses of the technology provides insight into the many potential benefits to humankind in the fields of medicine, education and beyond.

Reference
https://doi.org/10.33548/SCIENTIA494

Meet the researcher


Dr William Hurst

Department of Computer Science
Liverpool John Moores University
Liverpool
UK

Dr Hurst is a Reader (Associate Professor) in Creative Technologies in the Department of Computer Science at Liverpool John Moores University (LJMU). He has over 60 international publications in the areas of Data Visualisation, Artificial Intelligence, Machine Learning, Computer Graphics and Data Science. Dr Hurst has also had successful grants from the EPSRC, Innovate UK, SBRI and UKAIS for multiple projects within these areas.

CONTACT

E: W.Hurst@ljmu.ac.uk

W:  mycreativetechnologies.com

T: @WillLJMU

KEY COLLABORATORS

Andrew Sands and Shay O’Carroll, Imagin3D, Office 4, CTH, Sci Tech Daresbury, Warrington

The team at Imagin3D have over 12 years’ experience in 3D and immersive technologies, including Augmented/Virtual Reality and Serious Gaming. Imagin3D have produced 2 award winning immersive training environments and delivered the first Virtual Factory on the £20m pilot for the governments ‘manufacturing made smarter’ scheme. In2019, Imagin3D were shortlisted for the Halton Chamber New Business of the Year and won two academic best papers for their work in AR and VR field.

W: imagin3d.co.uk

T: @imagin3dltd

Dr John Barrow, Dean for Entrepreneurship & Employability, Institute of Medical Sciences, University of Aberdeen, Aberdeen

Dr Nathan Shone, Senior Lecturer, Liverpool John Moores University

Kieran Latham, PhD Student, Liverpool John Moores University

FUNDING

Productivity Accelerator (ProAccel) – InnovateUK/SBRI funding. £102, 000 – code: https://gtr.ukri.org/projects?ref=971582 – Project Reference: 971582

FURTHER READING

J Barrow, C Forker, A Sands, D O’Hare, W Hurst, Augmented reality for enhancing life science education, Paper presented at VISUAL 2019 – The fourth international conference on applications and systems of visual paradigms, Rome, Italy.

W Hurst, K Latham, D O’Hare, A Sands, RJ Gandy, A case study on the development of a virtual reality proton beam unit, In: Interactive Digital Media 2018, 11 December 2018 – 12 December 2018, Liverpool.

W Hurst, N Shone, D Tully, Q Shi, C Chalmers, J Hulse, D O’Hare, Developing a productivity accelerator platform to support UK businesses in the industry 4.0 revolution. In: XS Yang, S Sherratt, N Dey, A Joshi, (eds), Third international congress on information and communication technology, advances in intelligent systems and computing, Vol. 797, Springer, Singapore.

Creative Commons Licence
(CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.


More articles you may like

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

Assoc Prof. Nicholas Brown | Rethinking Prostate Care: A New Frontier in Treating Benign Prostatic Hyperplasia

For millions of men, ageing brings with it a set of frustrating and often disruptive urinary symptoms. These symptoms, caused by benign prostatic hyperplasia, or BPH, can affect sleep, confidence, and overall quality of life. Traditionally, treatment follows a familiar path. Patients begin with medications, often for years, and may eventually progress to surgery if symptoms worsen. Yet this pathway is not without its drawbacks. Medications can cause side effects, while surgery carries risks and recovery time. In recent years, a minimally invasive interventional radiology procedure called prostate artery embolisation, or PAE, has begun to challenge this traditional model. At the forefront of this shift is a collaborative research group, led by Dr. Nicholas Brown of the University of Queensland, whose series of P-EASY studies has explored whether PAE could transform how BPH is treated, particularly at earlier stages.

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Jean Lycke | Addressing Unmet Medical Needs in Mucosal Disease: A Close-to-Market Innovation Approach

Recurrent Aphthous Stomatitis (RAS) is an oral condition characterized by one or several painful mucosal ulcers. RAS affects a large proportion of the population and has a point prevalence of approximately 2–3%, daily. The etiology remains unknown, and there is currently no curative treatment. Most patients experience recurring episodes over time, with each episode typically lasting up to a week. Here, we describe the development of a mucoadhesive patch which, when applied over a RAS ulcer, provides rapid pain relief. The patch is easy for patients to apply when symptoms begin and has the potential to be used as an over-the-counter product. The development of the Mucocort mucoadhesive patch is an example of a Close-to-Market innovation strategy that embraces simplicity within a complex healthcare system. By simplifying the product concept, the team has reduced the number of regulatory steps required before market approval. This MedTech/Pharma innovation model, known as the “4R” framework – Re-purposing, Re-formulation, Re-positioning, and Re-patenting – has guided the program from concept to commercialization. In addition to the biodegradable mucoadhesive patch developed for RAS ulcers, the team is extending the innovation concept to a mucoadhesive gel formulation for the prevention and treatment of chemotherapy-induced mucositis. This gel-based program is being commercialized separately through MucoShield.

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

The Translational Asian Agerelated Macular Degeneration Program Phase 2 (TAAP-2): Reimagining the Future of Vision Care

Age-related macular degeneration, often abbreviated as AMD, is one of the leading causes of vision loss among older adults worldwide. In Asia, where populations are ageing rapidly, its impact is particularly profound. For many, the disease quietly erodes central vision, making everyday activities such as reading, driving, and recognising faces increasingly difficult. Against this backdrop, the Translational Asian Age-related Macular Degeneration Programme, or TAAP for short, has emerged as a bold and ambitious effort to confront the disease headon. Now in its second phase, TAAP-2 represents a significant evolution in both scientific scope and clinical ambition.

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

Ms. Aikaterini Dritsoula | Looking Beyond Snoring: How Hidden Airway Problems Shape Children’s Sleep

For many parents, a child’s snoring may seem harmless, even endearing. Yet in some cases, it signals something more serious. Obstructive sleep apnoea is a condition in which a child’s breathing is repeatedly disrupted during sleep. These interruptions can affect growth, behaviour, and learning. Children with this condition may toss and turn at night, struggle to concentrate during the day, or show signs of hyperactivity and fatigue. Traditionally, enlarged tonsils and adenoids have been seen as the main culprits. Surgery to remove them has long been considered the standard treatment. However, research led by Consultant ENT Surgeon Ms. Aikaterini Dritsoula of The Leeds Teaching Hospitals NHS Trust invites us to look deeper. Her work suggests that the story is often more complex, especially in very young children.